CRYO CELL INTERNATIONAL INC
For the period ended Feb 28, 2026. Filed Apr 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 28, 2026 · Filed Apr 14, 2026
CCEL$4.87-0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
| For the Three Months Ended | ||
|---|---|---|
| February 28, | February 28, | |
| 2026 | 2025 | |
| Revenue: | ||
| Processing and storage fees | $7,643,113 | $7,865,888 |
| Public banking revenue | 1,410 | 82,079 |
| Product revenue | 38,594 | 20,913 |
| Total revenue | 7,683,117 | 7,968,880 |
| Costs and Expenses: | ||
| Cost of sales | 1,656,488 | 1,984,588 |
| Selling, general and administrative expenses | 5,011,847 | 4,638,285 |
| Research, development and related engineering | 65,761 | 98,143 |
| Depreciation and amortization | 183,887 | 191,853 |
| Total costs and expenses | 6,917,983 | 6,912,869 |
| Operating Income | 765,134 | 1,056,011 |
| Other Income (Expense): | ||
| Losses on marketable securities | (240,458) | (31,401) |
| Other income | 8,342 | 4,070 |
| Interest expense | (462,709) | (494,962) |
| Total other (expense) income | (694,825) | (522,293) |
| Income before income tax expense | 70,309 | 533,718 |
| Income tax expense | (23,201) | (250,863) |
| Net income | $47,108 | $282,855 |
| Net income per common share - basic | $0.01 | $0.03 |
| Weighted average common shares outstanding - basic | 8,055,150 | 8,082,159 |
| Net income per common share - diluted | $0.01 | $0.03 |
| Weighted average common shares outstanding - diluted | 8,056,133 | 8,200,022 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.